Aurora Cannabis (ACB) Income from Discontinued Operations (2020 - 2026)
Aurora Cannabis (ACB) posted quarterly Income from Discontinued Operations of 56015393.64 for Q1 2026, down 615.22% year-on-year from 10872201.18 in Q1 2025, and down 48722.05% on a QoQ basis from 114733.81 in Q4 2025.
Aurora Cannabis (ACB) Income from Discontinued Operations (2020 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Income from Discontinued Operations for 7 consecutive years, with 56015393.64 the latest figure, recorded in Q1 2026.
- Quarterly Income from Discontinued Operations fell 615.22% year-over-year to 56015393.64 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56395146.63 (down 208.86% YoY) and the FY2026 annual result came in at 55967585.69, down 205.6% from the prior year.
- Income from Discontinued Operations fell to 56015393.64 in Q1 2026 per ACB's latest filing, from 114733.81 in the prior quarter.
- Over the last five years, Income from Discontinued Operations for ACB reached as high as 222266.73 in Q2 2024 and fell as low as 56015393.64 in Q1 2026.
- A 5-year average of 7360325.25 and a median of 1406995.57 in 2024 frame the typical range for Income from Discontinued Operations.
- Annual changes were most pronounced in 2022 — Income from Discontinued Operations tumbled 883.35% — and 2024, when it soared 132.49%.
- Year by year, Income from Discontinued Operations stood at 13350530.68 in 2022, then soared by 98.1% to 253414.76 in 2023, then surged by 132.49% to 82322.65 in 2024, then tumbled by 239.37% to 114733.81 in 2025, then tumbled by 48722.05% to 56015393.64 in 2026.
- According to Business Quant data, Income from Discontinued Operations over the past three periods registered 56015393.64, 114733.81, and 84289.66 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.14 Bn | 20.98 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.42 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.58 Bn | 12.15 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 156.25 Mn | 71.00 Mn | 21.72 Mn | -56.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.02 Mn |
| Dec 31, 2025 | -114,733.81 |
| Sep 30, 2025 | 84,289.66 |
| Jun 30, 2025 | -349,308.85 |
| Mar 31, 2025 | -7.83 Mn |
| Dec 31, 2024 | 82,322.65 |
| Sep 30, 2024 | -10.73 Mn |
| Jun 30, 2024 | 222,266.73 |
| Mar 31, 2024 | -1.44 Mn |
| Dec 31, 2023 | -253,414.76 |
| Sep 30, 2023 | -1.78 Mn |
| Dec 31, 2022 | -13.35 Mn |
| Sep 30, 2022 | -10.19 Mn |
| Jun 30, 2022 | -1.38 Mn |
| Jun 30, 2021 | 175,721.87 |
| Sep 30, 2020 | -1.37 Mn |